Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 162828206 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Beryl Capital Management LLC
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Beryl Capital Management LLC | 0% | ||
| Beryl Capital Management LP | 0% | ||
| Beryl Capital Partners II LP | 0% | ||
| David A. Witkin | 0% | ||
| Fortress Biotech, Inc. 13D/A Amendment 11 | 0% |
6/3/2025
Event 5/30/2025
|
|
|
Armistice Capital, LLC
13G/A
Amendment 4
|
4.99% |
5/15/2025
Event 3/31/2025
|
|
| Armistice Capital, LLC | 4.99% | ||
| Steven Boyd | 4.99% | ||
|
Glazer Capital, LLC
13G/A
Amendment 1
|
3.8% |
5/15/2025
Event 3/31/2025
|
|
| Glazer Capital, LLC | 3.8% | ||
| Paul J. Glazer | 3.8% | ||
|
Glazer Capital, LLC
13G
|
6.4% |
3/17/2025
Event 3/10/2025
|
|
| Glazer Capital, LLC | 6.4% | ||
| Paul J. Glazer | 6.4% | ||
|
Beryl Capital Management LLC
13G
|
9.9% |
3/17/2025
Event 3/10/2025
|
|
| Beryl Capital Management LLC | 9.9% | ||
| Beryl Capital Management LP | 9.9% | ||
| Beryl Capital Partners II LP | 8.0% | ||
| David A. Witkin | 9.9% | ||
| Fortress Biotech, Inc. 13D/A Amendment 10 | 11.2% |
3/11/2025
Event 3/9/2025
|
|
|
Armistice Capital, LLC
13G/A
Amendment 3
|
10.0% |
2/14/2025
Event 12/31/2024
|
|
| Armistice Capital, LLC | 10.0% | ||
| Steven Boyd | 10.0% | ||
| Fortress Biotech, Inc. 13D/A Amendment 9 | 13.5% |
1/3/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q1 | 94 | 34.1 M | $138 M |
| 2024 Q4 | 75 | 11.1 M | $35.5 M |
| 2024 Q3 | 52 | 7.69 M | $17.1 M |
| 2024 Q2 | 52 | 5.89 M | $12.5 M |
| 2024 Q1 | 46 | 5.40 M | $11.1 M |
| 2023 Q4 | 50 | 4.89 M | $11.2 M |
| 2023 Q3 | 43 | 3.93 M | $6.67 M |
| 2023 Q2 | 40 | 2.67 M | $10.2 M |
| 2023 Q1 | 38 | 1.40 M | $3.14 M |
| 2022 Q4 | 45 | 1.93 M | $23.5 M |